2023 ACC/AHA/ACCP/HRS guideline for the diagnosis and management of atrial fibrillation: a report of the American College of Cardiology/American Heart …

JA Joglar, MK Chung, AL Armbruster, EJ Benjamin… - Circulation, 2024 - Am Heart Assoc
AIM The “2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial
Fibrillation” provides recommendations to guide clinicians in the treatment of patients with …

[HTML][HTML] 2021 guideline for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline from the American Heart Association/American …

DO Kleindorfer, A Towfighi, S Chaturvedi, KM Cockroft… - Stroke, 2021 - journals.lww.com
1. Specific recommendations for prevention strategies often depend on the ischemic
stroke/transient ischemic attack subtype. Therefore, new in this guideline is a section …

JCS/JHRS 2019 guideline on non-pharmacotherapy of cardiac arrhythmias

A Nogami, T Kurita, H Abe, K Ando, T Ishikawa… - Circulation …, 2021 - jstage.jst.go.jp
Pacemaker treatment for bradyarrhythmia was first approved for national health insurance
coverage in Japan in 1974, and its use rapidly became widespread thereafter …

4-year outcomes after left atrial appendage closure versus nonwarfarin oral anticoagulation for atrial fibrillation

P Osmancik, D Herman, P Neuzil, P Hala… - Journal of the American …, 2022 - jacc.org
Abstract Background The PRAGUE-17 (Left Atrial Appendage Closure vs Novel
Anticoagulation Agents in Atrial Fibrillation) trial demonstrated that left atrial appendage …

2019 AHA/ACC/HRS focused update of the 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of …

CT January, LS Wann, H Calkins, LY Chen… - Circulation, 2019 - Am Heart Assoc
The purpose of this document is to update the “2014 AHA/ACC/HRS Guideline for the
Management of Patients With Atrial Fibrillation” S1. 3-1 (2014 AF Guideline) in areas for …

Antithrombotic therapy for atrial fibrillation: CHEST guideline and expert panel report

GYH Lip, A Banerjee, G Boriani, C en Chiang, R Fargo… - Chest, 2018 - Elsevier
Background The risk of stroke is heterogeneous across different groups of patients with atrial
fibrillation (AF), being dependent on the presence of various stroke risk factors. We provide …

5-year outcomes after left atrial appendage closure: from the PREVAIL and PROTECT AF trials

VY Reddy, SK Doshi, S Kar, DN Gibson… - Journal of the American …, 2017 - jacc.org
Abstract Background: The PROTECT AF (WATCHMAN Left Atrial Appendage System for
Embolic Protection in Patients With Atrial Fibrillation) trial demonstrated that left atrial …

The NCDR left atrial appendage occlusion registry

JV Freeman, P Varosy, MJ Price, D Slotwiner… - Journal of the American …, 2020 - jacc.org
Background Left atrial appendage occlusion (LAAO) to prevent stroke in patients with atrial
fibrillation has been evaluated in 2 randomized trials; post-approval clinical data are limited …

[PDF][PDF] 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS

P Kirchhof, S Benussi, D Kotecha… - Polish Heart …, 2016 - journals.viamedica.pl
Komisję ESC ds. Wytycznych Postępowania nadzoruje i koordynuje przygotowywanie
nowych wytycznych i stanowisk przez grupy robocze i inne grupy ekspertów. Komitet jest …

心房颤动: 目前的认识和治疗建议-201

黄从新, 张澍, 黄德嘉, 曹克将, 陈柯萍… - 中国心脏起搏与心电 …, 2015 - cqvip.com
自2012 年中华医学会心电生理和起搏分会(ChinaSoci—etyofPacingandElectrophysiology,
CSPE) 发表《 心房颤动: 目前的认识和治疗建议-2012) 以来的三年间, 有关心房颤动(简称房颤) …